Insider Transactions Reported by 15 Insiders of INNOVATE Corp.

Symbol
VATE on NYSE
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 15 Mar 2025

INNOVATE Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Avram A. Glazer Director, 10%+ Owner $43,316,765 04 Aug 2025
Paul Voigt Interim CEO $4,208,635 15 Sep 2025
Michael J. Sena Chief Financial Officer $967,604 14 Mar 2025
Kenneth S. Courtis Director $815,883 17 Jun 2021
Wayne Barr Jr. President and CEO, Director $646,257 23 May 2023
Joseph Anthony Ferraro Chief Legal Officer & Corp Sec $508,093 16 Mar 2022
Warren H. Gfeller Director $432,622 12 Jun 2025
Suzi R. Herbst Chief Operating Officer $422,590 15 Mar 2023
Brian S. Goldstein Director $313,001 12 Jun 2025
Amy Marie Wilkinson Director $299,716 12 Jun 2025
Shelly Lombard Director $46,321 15 Jun 2022
MG Capital Management Ltd. 10%+ Owner $36,204 01 Jul 2021
Continental General Holdings LLC 10%+ Owner 01 Jul 2021
Percy Rockdale LLC 10%+ Owner 19 Mar 2024
Michael Gorzynski 10%+ Owner 19 Mar 2024

Recent Insider Transactions by Companies or Individuals for INNOVATE Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Paul Voigt VATE Stock option (Right To Buy) Award 100,000 100,000 15 Sep 2025 Direct
Paul Voigt VATE Common Stock Award 39.1% 176,056 625,890 06 Aug 2025 Direct
Amy M. Wilkinson VATE Common Stock Award 53.6% 16,363 46,904 12 Jun 2025 Direct
Warren H. Gfeller VATE Common Stock Award 31.9% 16,363 67,703 12 Jun 2025 Direct
Avram A. Glazer VATE Common Stock Award 43.5% 16,363 53,984 12 Jun 2025 Direct
Brian S. Goldstein VATE Common Stock Award 50.2% 16,363 48,983 12 Jun 2025 Direct
Michael J. Sena VATE Common Stock Tax liability -0.84% -1,053 123,893 15 Mar 2025 Direct
Michael J. Sena VATE Common Stock Tax liability -3.33% -4,302 124,946 14 Mar 2025 Direct
Michael J. Sena VATE Common Stock Award 11.1% 12,946 129,248 13 Mar 2025 Direct
Michael J. Sena VATE Common Stock Tax liability -0.74% -862 116,302 11 Mar 2025 Direct
Avram A. Glazer VATE Common Stock Gift 2,097,902 2,097,902 16 Dec 2024 KAG Irrevocable Exempt Trust
Avram A. Glazer VATE Common Stock Gift 2,097,902 2,097,902 16 Dec 2024 LHG Irrevocable Exempt Trust
Avram A. Glazer VATE Common Stock Gift -99.1% -4,195,804 37,621 16 Dec 2024 Direct
Paul Voigt VATE Common Stock Purchase $99,500 $3.98 25,000 25,000 19 Nov 2024 Paul K Voigt Rev Trust
Paul Voigt VATE Common Stock Award 112.5% 238,179 449,834 29 Oct 2024 Direct
Paul Voigt VATE Stock option (Right To Buy) Award 200,000 100,000 29 Oct 2024 Direct
Paul Voigt VATE Common Stock Purchase 26.1% $166,383 $3.80 43,785 211,655 12 Sep 2024 Direct
Brian S. Goldstein VATE Common Stock Award 97.5% 161,001 326,194 18 Jun 2024 Direct
Amy M. Wilkinson VATE Common Stock Award 111.5% 161,001 305,406 18 Jun 2024 Direct
Avram A. Glazer VATE Common Stock Conversion of derivative security 230.6% 44,693,895 64,078,091 18 Jun 2024 Lancer Capital
Avram A. Glazer VATE Common Stock Award 74.8% 161,001 376,196 18 Jun 2024 Direct
Avram A. Glazer VATE Series C Non-Voting Participating Convertible Pref Stock Conversion of derivative security -100% -31,286 0 18 Jun 2024 By: Lancer Capital LLC
Warren H. Gfeller VATE Common Stock Award 45.7% 161,001 513,389 18 Jun 2024 Direct
Paul Voigt VATE Common Stock Purchase 0.01% $106 $0.6000 176 1,678,695 14 Jun 2024 Direct
Paul Voigt VATE Common Stock Purchase 0.42% $4,218 $0.6000 7,030 1,678,519 12 Jun 2024 Direct
Paul Voigt VATE Common Stock Purchase 0.53% $5,296 $0.6000 8,826 1,671,489 11 Jun 2024 Direct
Paul Voigt VATE Common Stock Purchase 0.12% $1,179 $0.6000 1,965 1,662,663 10 Jun 2024 Direct
Paul Voigt VATE Common Stock Options Exercise 28.6% 16,751 75,362 24 Apr 2024 Jessie Holdings LLC
Paul Voigt VATE Common Stock Options Exercise 28.6% 369,130 1,660,698 24 Apr 2024 Direct
Paul Voigt VATE Subscription Rights (right to buy) Options Exercise -100% -58,611 0 24 Apr 2024 Jessie Holdings LLC
Paul Voigt VATE Subscription Rights (right to buy) Options Exercise -100% -1,291,568 0 24 Apr 2024 Direct
Paul Voigt VATE Common Stock Options Exercise 28.6% 369,130 1,660,698 24 Apr 2024 Direct
Paul Voigt VATE Subscription Rights (right to buy) Options Exercise -100% -1,291,568 0 24 Apr 2024 Direct
Avram A. Glazer VATE Series C Non-Voting Participating Convertible Pref Stock Award 25.1% 6,286 31,286 24 Apr 2024 By: Lancer Capital LLC
Michael J. Sena VATE Common Stock Options Exercise 10.8% 114,285 1,171,632 24 Apr 2024 Direct
Michael J. Sena VATE Subscription Rights (right to buy) Options Exercise -100% -399,881 0 24 Apr 2024 Direct
Warren H. Gfeller VATE Common Stock Options Exercise 22% 63,428 352,388 24 Apr 2024 Direct
Warren H. Gfeller VATE Subscription Rights (right to buy) Options Exercise -100% -221,932 0 24 Apr 2024 Direct
Avram A. Glazer VATE Series C Non-Voting Participating Convertible Pref Stock Award 25,000 25,000 28 Mar 2024 By: Lancer Capital LLC
Percy Rockdale LLC VATE Subscription Rights (right to buy) Sale -1.98% -100,000 4,948,755 19 Mar 2024 Direct
Michael Gorzynski VATE Subscription Rights (right to buy) Sale -1.98% -100,000 4,948,755 19 Mar 2024 By: Percy Rockdale LLC
Michael J. Sena VATE Common Stock Sale -1.99% $13,349 $0.6217 -21,471 1,057,347 15 Mar 2024 Direct
Michael J. Sena VATE Common Stock Sale -1.07% $8,004 $0.6856 -11,675 1,078,818 14 Mar 2024 Direct
Michael J. Sena VATE Common Stock Award 48.9% 358,015 1,090,493 14 Mar 2024 Direct
Warren H. Gfeller VATE Common Stock Award 19.1% 46,392 288,960 15 Jun 2023 Direct
Brian S. Goldstein VATE Common Stock Award 39% 46,392 165,193 15 Jun 2023 Direct
Avram A. Glazer VATE Common Stock Award 27.5% 46,392 215,195 15 Jun 2023 Direct
Amy M. Wilkinson VATE Common Stock Award 47.3% 46,392 144,405 15 Jun 2023 Direct
Wayne Barr Jr. VATE Common Stock Purchase 1.16% $7,400 $1.48 5,000 436,660 23 May 2023 Direct
Wayne Barr Jr. VATE Common Stock Purchase 1.11% $7,362 $1.55 4,750 431,660 18 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.